Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 5Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Leukemia 4Myelodysplastic Syndromes 2Leukemia, Myeloid, Acute 2Hematologic Neoplasms 2Thrombocytopenia 1Retinal Diseases 1Primary Myelofibrosis 1Neoplasms, Plasma Cell 1Myasthenia Gravis 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia, Myeloid 1Hodgkin Disease 1Graft vs Host Disease 1Congenital Abnormalities 1Anemia 1

Interventions

Cyclophosphamide 12Methotrexate 9Antilymphocyte Serum 9fludarabine phosphate 8Tacrolimus 8Cyclosporine 8Mycophenolic Acid 6Whole-Body Irradiation 5Radiotherapy 5Busulfan 5thymoglobulin 4Sirolimus 4Methylprednisolone 4Filgrastim 4Alemtuzumab 4fludarabine 3Transplantation 3Rituximab 3Peripheral Blood Stem Cell Transplantation 3Melphalan 3Cord Blood Stem Cell Transplantation 3Thiotepa 2Therapeutics 2Stem Cell Transplantation 2Muromonab-CD3 2Immunosuppression Therapy 2Calcineurin Inhibitors 2visilizumab 1milatuzumab 1itacitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Graft vs Host Disease × Hematopoietic Stem Cell Transplantation × Clear all
NCT00506948 2020-09-24

Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD)

M.D. Anderson Cancer Center

Phase 2 Terminated
13 enrolled 5 charts
LymphoidMyeloidOther hematologic neoplasm

Graft vs Host Disease, Leukemia, Lymphoma, Myelodysplastic Syndromes, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡